CBPE sells Rosemont to Perrigo
Mid-market private equity firm CBPE Capital has sold Rosemont Pharmaceuticals to Perrigo, the USD10bn US listed pharmaceuticals business. CBPE acquired Rosemont in August 2006 for GBP93m. The sale to Perrigo represents an investment multiple of 3.25x CBPE’s GBP52m equity investment over the investment period for CBPE’s investors. Rosemont develops,